Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Stage-specific differences in medication adherence, regimen complexity, and medication-related issues in chronic kidney disease: A 1-year prospective observational study.

Created on 20 Nov 2026

Authors

Jun Kit Beh, Farida Islahudin, Adyani Md Redzuan, Kiew Bing Pau

Published in

Research in social & administrative pharmacy : RSAP. Nov 17, 2026. Epub Nov 17, 2026.

Abstract

As chronic kidney disease (CKD) progresses, medication management becomes increasingly challenging. However, direct comparisons across the CKD continuum are limited.
To characterise stage-specific differences in medication management by comparing medication adherence, regimen complexity and medication-related issues among patients with mild, moderate and severe CKD over a 1-year period.
A prospective observational study among adults receiving nephrology care at a tertiary hospital in Kuala Lumpur, Malaysia. Patients were grouped as mild (stages 1-2), moderate (stages 3A-3B) and severe CKD (stages 4-5). A questionnaire was used to assess adherence using a validated prediction model assessing each medication taken, regimen complexity using the Medication Regimen Complexity Index (MRCI), and medication-related issues.
A total of 531 adult CKD patients were included. Good adherence declined with increasing CKD severity at baseline, from 47.24% (n = 77) in mild to 29.17% (n = 63) in moderate and 7.89% (n = 12) in severe CKD (p < 0.001), with a similar pattern at 1-year [66.67% (n = 48), 51.63% (n = 79), and 8.50% (n = 26), respectively; p < 0.001]. Overall, poor adherence remained high at baseline [71.37% (n = 379)] and 1-year [71.19% (n = 378)], with no significant changes between both time points (McNemar p = 0.655). Median MRCI scores were highest in severe CKD at both baseline [37.50 (IQR 32.88-46.25)] and 1-year [34.00 (23.63-42.00)], with significantly higher regimen complexity in severe CKD stages at both timepoints (both p < 0.001). Medication-related issues affected 87.95% (n = 467) patients at both timepoints. At baseline they were least frequent in severe CKD (75.66%) compared to mild (93.25%) and moderate (92.59%) (p < 0.001), but by 1-year it no longer differed by stage (p = 0.243).
Medication management differs substantially across CKD stages, possibly due to the pronounced adherence gap and a high overall burden of medication-related issues. The findings support stage-specific pharmacist-led medication review, with particular attention to adherence assessment and the identification of medication-related issues as patients progress through the CKD continuum.

PMID:
43057926
Bibliographic data and abstract were imported from PubMed on 20 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 3
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement